Epigenetically silenced PD-L1 confers drug resistance to anti-PD1 therapy in gastric cardia adenocarcinoma

Tianyu Zhu(University of Helsinki), Guojun Wang(First Affiliated Hospital of Zhengzhou University), Ruixin Li(First Affiliated Hospital of Zhengzhou University), Hengxuan Ding(First Affiliated Hospital of Zhengzhou University), Zhuoyin Wang(Capital Medical University), Junfeng Sun(Kunming University of Science and Technology), Zhihao Hu(First Affiliated Hospital of Zhengzhou University)
International Immunopharmacology
February 21, 2020
10.1016/j.intimp.2020.106245
Cited by 15

Related Papers

The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition
|Journal of Translational Medicine|2016|158
RETRACTED ARTICLE: LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer
|Journal of Experimental & Clinical Cancer Research|2018|92
A Comprehensive Comparison of LRYGB and LSG in Obese Patients Including the Effects on QoL, Comorbidities, Weight Loss, and Complications: a Systematic Review and Meta-Analysis
|Obesity Surgery|2019|89
A cell-type deconvolution meta-analysis of whole blood EWAS reveals lineage-specific smoking-associated DNA methylation changes
|Nature Communications|2020|70
microRNA-301b-3p from mesenchymal stem cells-derived extracellular vesicles inhibits TXNIP to promote multidrug resistance of gastric cancer cells
|Cell Biology and Toxicology|2022|54